Kailaiying

Asymchem is a leading global Contract Development and Manufacturing Organization (CDMO) providing integrated solutions throughout the drug R&D and commercialization lifecycle. Founded in 1998 and headquartered in Tianjin, China, the company specializes in small molecule drug development, green chemistry, and continuous flow manufacturing. Asymchem has expanded its capabilities into emerging areas such as biologics, oligonucleotides, peptides, and antibody-drug conjugates (ADCs). The company serves a global clientele, including major pharmaceutical companies and emerging biotech firms, through its extensive network of R&D and manufacturing facilities in China and the United States. Its commitment to sustainable manufacturing and technological innovation has made it a preferred partner for complex chemical synthesis and large-scale production.